Coupa Software (NASDAQ: COUP), a technology firm with a focus on Business Spend Management, is slated to report second-quarter 2020 financial results after the closing bell on Tuesday, September 3.
Wall Street expects to see continued growth in top-line, helped by the strength in subscriber revenues. Analysts expect the San Mateo, California-based firm to report a 38.5% increase in revenues to $85.38 million.
The analysts’ expectation falls within the management projection range of Q2 revenues between $84.5 million and $85.5 million. The management had also projected subscription revenues in the range of $77-78 million.
For the second quarter, the management expects an adjusted loss of 10-12 cents per share. The street estimate is pegged at the lower end of this projection range at 10 cents per share loss. In three of the past four quarters, the software company had surpassed Wall Street projections on the bottom-line, while it was in line with the estimate once.
Coupa had recently forged partnerships with PayPal (NASDAQ: PYPL) and Citigroup (NYSE: C) with a focus on making business payments more efficient. The company had also last month acquired contract lifecycle management solutions firm Exari to integrate into its BSM platform. Look out for any updates on how these alliances are working out financially for the firm.
Coupa had an exceptionally good year so far, with its stock soaring 126% in the year-to-date period. During the same period, the iShares Expanded Tech-Software ETF has gained just 24%.
Coupa is currently trading near its 12-month price target, so a post-earnings rally may be unlikely.
Neurological and neurodegenerative diseases affect a vast segment of the population worldwide and there is a significant demand for treatments for these conditions. Biogen (BIIB) has a strong portfolio of
Teva Pharmaceutical Industries Ltd. (NYSE: TEVA), a market leader in generic drugs, reported lower revenues for the third quarter of 2021, citing a slowdown in North American sales. Meanwhile, earnings
Goldman Sachs (GS) exceeded analysts’ expectations, as investment banking revenue surged nearly 90%. Goldman market research report covers key aspects about the firm including company profile, financial highlights and key